GD2
General | Antibody | Glycoprotein | Glycolipid | Enzyme | Reference24 reference for EP0061
| sort by year ∧ ∨ | Reference detail |
|---|---|
| 1 | Kawashima I, Nagata I, Tai T. Immunocytochemical analysis of gangliosides in rat primary cerebellar cultures using specific monoclonal antibodies. Brain Res. 1996 Sep 2;732(1-2):75-86 PMID: 8891271 |
2 | Kotani M, Kawashima I, Ozawa H, Ogura K, Ishizuka I, Terashima T, Tai T. Immunohistochemical localization of minor gangliosides in the rat central nervous system. Glycobiology. 1994 Dec ;4(6):855-65 PMID: 7734848 |
3 | Kawashima I, Ozawa H, Kotani M, Suzuki M, Kawano T, Gomibuchi M, Tai T. Characterization of ganglioside expression in human melanoma cells: immunological and biochemical analysis. J Biochem (Tokyo). 1993 Aug ;114(2):186-93 PMID: 8262898 |
4 | Ravindranath MH, Muthugounder S, Presser N, Selvan SR, Portoukalian J, Brosman S, Morton DL. Gangliosides of organ-confined versus metastatic androgen-receptor-negative prostate cancer. Biochem Biophys Res Commun. 2004 Nov 5;324(1):154-65 PMID: 15464996 |
5 | Ozawa H, Kotani M, Kawashima I, Tai T. Generation of one set of monoclonal antibodies specific for b-pathway ganglio-series gangliosides. Biochim Biophys Acta. 1992 Jan 24;1123(2):184-90 PMID: 1371229 |
6 | Zenita K, Hirashima K, Shigeta K, Hiraiwa N, Takada A, Hashimoto K, Fujimoto E, Yago K, Kannagi R. Northern hybridization analysis of VH gene expression in murine monoclonal antibodies directed to cancer-associated ganglioside antigens having various sialic acid linkages. J Immunol. 1990 Jun 1;144(11):4442-51 PMID: 2111348 |
7 | Sen G, Chakraborty M, Foon KA, Reisfeld RA, Bhattacharya-Chatterjee M. Preclinical evaluation in nonhuman primates of murine monoclonal anti-idiotype antibody that mimics the disialoganglioside GD2. Clin Cancer Res. 1997 Nov ;3(11):1969-76 PMID: 9815586 |
8 | Sen G, Chakraborty M, Foon KA, Reisfeld RA, Bhattacharya-Chatterjee MB. Induction of IgG antibodies by an anti-idiotype antibody mimicking disialoganglioside GD2. J Immunother. 1998 Jan ;21(1):75-83 PMID: 9456440 |
9 | Lode HN, Handgretinger R, Schuermann U, Seitz G, Klingebiel T, Niethammer D, Beck J. Detection of neuroblastoma cells in CD34+ selected peripheral stem cells using a combination of tyrosine hydroxylase nested RT-PCR and anti-ganglioside GD2 immunocytochemistry. Eur J Cancer. 1997 Oct ;33(12):2024-30 PMID: 9516847 |
10 | Vriesendorp FJ, Quadri SM, Flynn RE, Malone MR, Cromeens DM, Stephens LC, Vriesendorp HM. Preclinical analysis of radiolabeled anti-GD2 immunoglobulin G. Cancer. 1997 Dec 15;80(12 Suppl):2642-9 PMID: 9406719 |
11 | Yuki N, Yamada M, Tagawa Y, Takahashi H, Handa S. Pathogenesis of the neurotoxicity caused by anti-GD2 antibody therapy. J Neurol Sci. 1997 Aug ;149(2):127-30 PMID: 9171318 |
12 | Cheresh DA, Harper JR, Schulz G, Reisfeld RA. Localization of the gangliosides GD2 and GD3 in adhesion plaques and on the surface of human melanoma cells. Proc Natl Acad Sci U S A. 1984 Sep ;81(18):5767-71 PMID: 6385004 |
13 | Yamaguchi H, Furukawa K, Fortunato SR, Livingston PO, Lloyd KO, Oettgen HF, Old LJ. Human monoclonal antibody with dual GM2/GD2 specificity derived from an immunized melanoma patient. Proc Natl Acad Sci U S A. 1990 May ;87(9):3333-7 PMID: 2159145 |
14 | Tai T, Kawashima I, Tada N, Dairiki K. Different fine binding specificities of monoclonal antibodies to disialosylganglioside GD2. J Biochem (Tokyo). 1988 Apr ;103(4):682-7 PMID: 3170507 |
15 | Mujoo K, Cheresh DA, Yang HM, Reisfeld RA. Disialoganglioside GD2 on human neuroblastoma cells: target antigen for monoclonal antibody-mediated cytolysis and suppression of tumor growth. Cancer Res. 1987 Feb 15;47(4):1098-104 PMID: 3100030 |
16 | Cheung NK, Saarinen UM, Neely JE, Landmeier B, Donovan D, Coccia PF. Monoclonal antibodies to a glycolipid antigen on human neuroblastoma cells. Cancer Res. 1985 Jun ;45(6):2642-9 PMID: 2580625 |
17 | Cahan LD, Irie RF, Singh R, Cassidenti A, Paulson JC. Identification of a human neuroectodermal tumor antigen (OFA-I-2) as ganglioside GD2. Proc Natl Acad Sci U S A. 1982 Dec ;79(24):7629-33 PMID: 6296843 |
18 | Vick WW, Tello JW, Wikstrand CJ, He X, Longee D, Fredman P, Svennerholm L, Bigner DD, Johnston WW, Bigner SH. Application of a panel of antiganglioside monoclonal antibodies to cytologic specimens. Acta Cytol. 1992 Sep ;36(5):697-705 PMID: 1523927 |
19 | Longee DC, Wikstrand CJ, Mansson JE, He X, Fuller GN, Bigner SH, Fredman P, Svennerholm L, Bigner DD. Disialoganglioside GD2 in human neuroectodermal tumor cell lines and gliomas. Acta Neuropathol (Berl). 1991 ;82(1):45-54 PMID: 1659106 |
20 | Schulz G, Cheresh DA, Varki NM, Yu A, Staffileno LK, Reisfeld RA. Detection of ganglioside GD2 in tumor tissues and sera of neuroblastoma patients. Cancer Res. 1984 Dec ;44(12 Pt 1):5914-20 PMID: 6498849 |
21 | Cheresh DA, Rosenberg J, Mujoo K, Hirschowitz L, Reisfeld RA. Biosynthesis and expression of the disialoganglioside GD2, a relevant target antigen on small cell lung carcinoma for monoclonal antibody-mediated cytolysis. Cancer Res. 1986 Oct ;46(10):5112-8 PMID: 3019521 |
22 | Cheresh DA, Pierschbacher MD, Herzig MA, Mujoo K. Disialogangliosides GD2 and GD3 are involved in the attachment of human melanoma and neuroblastoma cells to extracellular matrix proteins. J Cell Biol. 1986 Mar ;102(3):688-96 PMID: 3005335 |
23 | Thurin J, Thurin M, Kimoto Y, Herlyn M, Lubeck MD, Elder DE, Smereczynska M, Karlsson KA, Clark WM Jr, Steplewski Z, et al. Monoclonal antibody-defined correlations in melanoma between levels of GD2 and GD3 antigens and antibody-mediated cytotoxicity. Cancer Res. 1987 Mar 1;47(5):1229-33 PMID: 3815333 |
24 | Kawashima I, Tada N, Ikegami S, Nakamura S, Ueda R, Tai T. Mouse monoclonal antibodies detecting disialogangliosides on mouse and human T lymphomas. Int J Cancer. 1988 Feb 15;41(2):267-74 PMID: 2448252 |